R.F.K. Jr.’s Newest Mission: Getting Us Off Antidepressants
TL;DR
Health Secretary Robert F. Kennedy Jr. is advancing federal policies to incentivize 'deprescribing' of antidepressants, forcing a reckoning within psychiatry over its lack of training and research regarding long-term medication cessation while amplifying patient demands for support in discontinuing SSRIs.
🏛️ Federal Policy Shift 3 insights
Medicare billing codes now reimburse deprescribing
Kennedy introduced billing codes allowing providers to bill Medicare and Medicaid for the time-intensive process of helping patients taper off psychiatric medications.
Dear Colleague letter challenges default prescriptions
The letter urges clinicians to consider psychotherapy, sleep, and exercise before defaulting to SSRIs for depression and anxiety disorders.
Technical panels to establish tapering guidelines
New expert panels will develop clinical protocols for safely discontinuing SSRIs, with the American Psychiatric Association now participating after initially being excluded.
⚕️ Psychiatry's Training Gap 3 insights
Medical education focuses on starting, not stopping, drugs
Psychiatrists acknowledge that training emphasizes prescribing medications but offers minimal guidance on tapering patients off long-term regimens.
Long-term use exceeds research parameters
While the median duration of SSRI use is five years, most clinical trials only span 6-8 weeks, leaving doctors with little evidence regarding prolonged treatment effects.
Fear of discrediting mental health treatment
Some APA members worry that Kennedy's initiative represents a first step toward restricting access to psychiatric medications or discrediting the field entirely.
👥 Patient-Led Withdrawal 3 insights
Online communities pioneer DIY tapering methods
Patients frustrated by physician dismissal share protocols on forums like Surviving Antidepressants, using techniques like counting beads from capsules and pharmaceutical scales.
Severe withdrawal symptoms often misdiagnosed as relapse
Discontinuation effects including brain zaps, vertigo, and emotional flooding are frequently mistaken for returning mental illness rather than withdrawal from medication.
Emotional blunting drives desire to discontinue
Many long-term users report feeling 'numb' or missing intense emotional experiences, prompting them to seek their baseline personality after decades on medication.
Bottom Line
Patients considering stopping antidepressants should seek medically supervised tapering protocols rather than attempting DIY withdrawal, while the medical system must urgently develop research and training standards for safely discontinuing psychiatric medications.
More from New York Times Podcasts
View all
Art, Outrage and How the Culture Wars Began
Cultural historian Isaac Butler traces the birth of modern American culture wars to the 1980s and 90s, revealing how tactical playbooks pioneered during the 1970s Kanawha County textbook wars transformed art funding and expression into central political battlegrounds.
The Untold Story of Jeffrey Epstein’s Death
A New York Times investigation into Jeffrey Epstein's final weeks reveals new evidence—including a hidden suicide note and detailed accounts from his cellmates—suggesting his death in federal custody was suicide, despite years of persistent conspiracy theories.
The Battle Over A.I. in the Classroom
As the school year ended, a fierce battle emerged between tech companies pushing $100+ million of AI into classrooms and parents worried about cheating and cognitive development, while innovative teachers experiment with strictly controlled AI tools to enhance rather than replace student thinking.
How Getting Stoned With My Dad Helped Us Heal
Filmmaker Julian Brave Noisecat shares how reconnecting with his absent father through cannabis rituals and invented games like "Bong Hit Scrabble" helped heal decades of intergenerational trauma rooted in residential school violence, as he prepares to become a father himself.